A shadow economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.
Several experts said the demand for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and customer laws, risking penalties, legal action or prison.
Service Response and Material Elimination
Based on TikTok, the service has removed violative material and prohibited related keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at residence.
After minutes of joining one community, a vendor shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to potentially serious health risks”.
